Piero Barbanti

34PUBLICATIONS
88CO-AUTHORS
Regenerative medicine (incl. stem cells)Psychosocial aspects of childbirth and perinatal mental healthTraditional Chinese medicine and treatmentsEpidemiological methodsGlycoconjugates
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (34)

|Jul 23, 2026
Correction: Real‑World Response and Super‑Response to Eptinezumab over 48 Weeks in Migraine: The Prospective Multicenter EMBRACE III Study.

|Jul 15, 2026
Multidisciplinary Management of Women Suffering from Migraine: Rationale, Design and Results of a National Delphi Consensus.

|Jun 19, 2026
Is achieving higher standards in real-world migraine care feasible with anti-CGRP monoclonal antibodies preventive therapies?: Insights from the EUREkA cohort.

|Jun 09, 2026
Real-World Response and Super-Response to Eptinezumab over 48 Weeks in Migraine: The Prospective Multicenter EMBRACE III Study.

|May 27, 2026
Long-Term Effectiveness and Persistence Factors of Anti-CGRP Monoclonal Antibodies in Migraine: 2-Year Results From the EUREkA Cohort.

|Jan 28, 2026
Long-Term Effectiveness and Persistence Factors of Anti-CGRP Monoclonal Antibodies in Migraine: 2-Year Results From the EUREkA Cohort.

Edoardo Caronna, Rut Mas-de-Les-Valls, Gabriella Egeo

Pageof 6

Frequent Collaborators

6 joint publications

Cinzia Aurilia

5 joint publications

Claudia Altamura

5 joint publications

Fabrizio Vernieri

5 joint publications

Maria Albanese